| PUBCHEM ID |
91667748
|
| UNII |
S4UCZ2KJ39
|
| Preferred Term |
2-SULFAMOYLACETYL PHENOL-O-GLUCURONIDE
|
| CAS |
84557-58-4
|
| INCHIKEY |
ICROYMGWDZDLMJ-BYNIDDHOSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
NS(CC(c(cccc1)c1O[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1C(O)=O)=O)(=O)=O
|
| Total Surface Area |
254,02
|
| Relative PSA |
0,56031
|
| TPSA |
202,06
|
| cLogS |
-2,389
|
| MW |
391,352
|
| cLogP |
-2,4608
|
| H-Acceptors |
11
|
| H-Donors |
5
|
| Ro5 violations |
1
|
| Druglikeness |
-0,71997
|
| DrugScore |
0,572390106644004
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,5431
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,5048
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,2371
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,2784
|
| Carcinogenicity (Three-class) |
Non-required
|
